Author name: R A

More than 45 encapsulated cell therapies and encapsulation technologies are being evaluated across different phases of development – Roots Analysis

Extensive research on cell encapsulation strategies has enabled the development of a variety of technologies capable of immobilizing / enclosing therapeutic entities within biocompatible matrices / carriers. Such products offer a myriad of advantages, and have demonstrated the capability to address existing challenges related to cell therapies and certain other types of interventions as well. […]

More than 45 encapsulated cell therapies and encapsulation technologies are being evaluated across different phases of development – Roots Analysis Read More »

The DNA data storage market is anticipated to grow at an annualized rate of over 26% by 2035

Exponential increase in amount of digital data being generated, coupled to the limitations of conventional storage mediums, has created a need for sustainable storage options and DNA data storage has garnered significant interest as an alternative    London   Roots Analysis has announced the addition of DNA Data Storage Market, 2021-2035” report to its list

The DNA data storage market is anticipated to grow at an annualized rate of over 26% by 2035 Read More »

The CD-47 targeting therapeutics market is projected to grow at a CAGR of 42.9%, claims Roots Analysis

Upon realizing the potential of this novel target, industry stakeholders have initiated several R&D efforts focused on exploiting the use of CD47 as an effective biomarker for the diagnosis and treatment purposes.   Roots Analysis has announced the addition of “CD-47 Targeting Therapeutics Market, 2021-2035” report to its list of offerings.   In recent years,

The CD-47 targeting therapeutics market is projected to grow at a CAGR of 42.9%, claims Roots Analysis Read More »

The pharmaceutical contract manufacturing market is projected to grow at an annualized rate of ~7%, till 2030, claims Roots Analysis

Driven by the COVID-19 pandemic and increasing demand for small molecules, the pharmaceutical contract manufacturing market is anticipated to witness significant growth over the next decade.     Roots Analysis has announced the addition of “Pharmaceutical Contract Manufacturing Market (3rd Edition), 2021-2030” report to its list of offerings.   The report features an extensive study

The pharmaceutical contract manufacturing market is projected to grow at an annualized rate of ~7%, till 2030, claims Roots Analysis Read More »

The squamous non-small cell lung cancer market is projected to grow at a CAGR of 10.8% till 2030

Advances in molecular biology and tumor immunology have enabled the development of NSCLC targeting therapies, which have the ability to impede cancer growth by altering chemical reactions associated with oncogenic driver mutations   Roots Analysis has announced the addition of “Squamous Non-small Cell Lung Cancer Market, 2021-2031” report to its list of offerings.   Success

The squamous non-small cell lung cancer market is projected to grow at a CAGR of 10.8% till 2030 Read More »

The RNA targeting small molecule therapies market is projected to be worth around USD 8.3 billion in 2030

In the recent years, RNA’s potential as a target molecule for small molecules has been widely recognized; as a result, a number of industry players have developed their proprietary technologies for direct and indirect RNA targeting and are actively engaged in the discovery and development of therapies against a wide range of therapeutic disorder  

The RNA targeting small molecule therapies market is projected to be worth around USD 8.3 billion in 2030 Read More »

The patient recruitment and retention services market is estimated to be worth USD 5.3 billion in 2030

A steadily increasing demand for participants in clinical research studies, coupled to the complexities associated with patient enrolment, have prompted drug / therapy developers to outsource this process to specialty service providers   Roots Analysis  is pleased to announce the publication of its recent study, titled, “Patient Recruitment and Retention Services Marker, 2019-2030.”   The

The patient recruitment and retention services market is estimated to be worth USD 5.3 billion in 2030 Read More »

The oligonucleotide synthesis, modification and purification services market is anticipated to grow at a CAGR of 18%, till 2030

Over the past few years, oligonucleotide developers have outsourced complex manufacturing procedures to specialty contract manufacturing service providers, in order to address growing demand competitively, economically and profitably   Roots Analysis has announced the addition of “Oligonucleotide Synthesis, Modification and Purification Services Market: Focus on Research, Diagnostic and Therapeutic Applications, 2021-2030” report to its list

The oligonucleotide synthesis, modification and purification services market is anticipated to grow at a CAGR of 18%, till 2030 Read More »

China Biopharmaceutical Contract Manufacturing Market – Gaining Traction in the Pharmaceutical Industry

The “China Biopharmaceutical Contract Manufacturing Market, 2020-2030” report features an extensive study of the current market landscape and future opportunities associated with the contract manufacturing of biopharmaceuticals in China. The study also features a detailed analysis of key drivers and trends related to this evolving domain.   The current biopharmaceuticals market is characterized by high

China Biopharmaceutical Contract Manufacturing Market – Gaining Traction in the Pharmaceutical Industry Read More »

The porphyria therapies market is projected to grow at an annualized rate of 10.97% during the period 2021-2030

Several novel and innovative therapeutic approaches, both small molecule and biologics, are being currently investigated at various phases of development in order to avoid the beginning of disease-induced attacks and other long-term effects of porphyria   Roots Analysis has announced the addition of “Porphyria Targeting Therapies Market, 2021-2030” report to its list of offerings.  

The porphyria therapies market is projected to grow at an annualized rate of 10.97% during the period 2021-2030 Read More »